SONN   $5.91  -4.52% Market Closed After Close 6.0 1.52%

Sonnet Biotherapeutics Holdings Inc
Last Events:

2023-08-09 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-06 Signal in Stochastic changed from bearish weakening to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

2023-08-06 Signal in MACD changed from bearish weakening to bullish reversal. Oscillator MACD is in the negative territory it crossed the signal line from the bottom and grows. These factors mean that the market confirms the end of the downward trend. Last signal: main and signal line crossing.

2023-08-05 Trend pattern changed from канал to нисходящий треугольник.

2023-08-05 Signal in Stochastic changed from bearish to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: main and signal line crossing.

2023-08-05 Signal in MACD changed from bearish to bearish weakening. Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

2023-08-05 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-04 Trend pattern changed from расходящийся клин с наклоном вверх to канал.


Current temperature: 5.86
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 2
Target Price Mean 148.0000
Mean unverified/preliminary 148.0000 / 148.0000
Target Price Low / High 56.0000 / 240.0000
Median / STD DEV 148.0000 / 130.11
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None Sell None
rsi ActivelyBuy Sell None
macd None ActivelyBuy None
stoch ActivelyBuy None None
ma20 ActivelyBuy Sell None
ma50 ActivelyBuy None None
ma100 None Sell None
Candlestick PatternOct. 15, 2024 Three Gaps Down - pattern is a made up of four black candlesticks. Pattern appears on a uptrend and consists of three consecutive days each gapping lower on the open. Considered to be a bullish reversal pattern.
ISIN US83548R4020
ceo Dr. Pankaj Mohan Ph.D.
Website https://www.sonnetbio.com
Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 that is in Phase 1b/2a clinical trial for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6, which is in Phase 1b/I2a clinical trail to treat chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy; and SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer. It has a license agreement with New Life Therapeutics Pte, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.